id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2011-N-0898-0002,FDA,FDA-2011-N-0898,"OMB Changes - CDER2011187 Applications for Food and Drug Administration Approval to Market a New Drug: Revision of Postmarketing Reporting Requirements - Discontinuance; Interim final rule; request for comments, dated February 24, 2012",Other,Memo,2012-02-28T05:00:00Z,2012,2,2012-02-28T05:00:00Z,,2012-02-28T13:15:53Z,,0,0,0900006480fc48e2